OPXA: Opexa Therapeutics, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Opexa Therapeutics, Inc.

NASDAQ:OPXA

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$10.04
Loss Chance
58.4%
1.88JITTA SCORE
n/a
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Sorry, the data is not yet available for this stock.
Jitta Factors
Growth Opportunity (30)
Recent Business Performance (40)
Financial Strength (10)
Return to Shareholders (0)
Competitive Advantage (0)
Jitta Signs
Operating MarginDeclined
Recent Business PerformanceEarning decline 42.24% in the last year
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
1.88
n/a
2.22
133.02%
n/a
n/a
COMPANY DESCRIPTION
As of September 19, 2017, Opexa Therapeutics, Inc. was acquired by Acer Therapeutics Inc., in a reverse merger transaction. Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases based on its proprietary T-cell technology. The company’s lead product candidate is Tcelna, a T-cell immunotherapy for the treatment of patients with secondary progressive MS. It is also developing OPX-212, an autologous T-cell immunotherapy that is in preclinical development to treat neuromyelitis optica. The company was formerly known as PharmaFrontiers Corp. and changed its name to Opexa Therapeutics, Inc. in June 2006. Opexa Therapeutics, Inc. was founded in 2003 and is headquartered in The Woodlands, Texas.
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.